Endobronchial Involvement in Granulomatosis with Polyangiitis

Coşkun DOĞAN1* (0000-0002-6948-5187), Göksel MENEK1 (0000-0002-6907-9963) , Deniz ANLAR2(0009-0003-9418-0048), Tuğçe BOZKURT3 (0000-0002-5135-4293)

¹Istanbul Medeniyet University Faculty of Medicine, Department of Pulmonology, Istanbul, Turkey.

²Istanbul Medeniyet University Faculty of Medicine, Department of Pathology, Istanbul, Turkey.

³Istanbul Medeniyet University Faculty of Medicine, Department of Romatology, Istanbul, Turkey.

*Corresponding author

*Coşkun Doğan , Istanbul Medeniyet University Faculty of Medicine, Department of Pulmonology, Istanbul, Turkey.

Abstract

In Granulomatosis with Polyangiitis (GPA) disease, a wide range of lung findings such as nodules, cavitary lesions, interstitial involvement, alveolar hemorrhage and tracheobronchial stenosis can be observed radiologically. While lung involvement is common, endobronchial involvement is relatively less common. It has been reported that the majority of cases of GPA with active endobronchial lesions (EBL) may have involvement of more organs and systems, primarily including the ear, nose, and throat.

This article presents a case of GPA in a 47-year-old male patient who presented with complaints of bloody nasal discharge, weakness, weight loss, cough, and wheezing.

Keywords: Fiberoptic Bronchoscopy, Endobronchial lesion, Granulomatosis with polyangiitis.

Endobronchial Involvement in Granulomatosis with Polyangiitis

Granulomatosis with Polyangiitis (GPA), previously known as Wegener's Granulomatosis, is a vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCAs). Radiologically, a wide spectrum of pulmonary manifestations can be observed.Including nodules, cavitary lesions, interstitial involvement, alveolar hemorrhage, and tracheobronchial stenosis. While pulmonary involvement is commonly observed, endobronchial involvement is relatively less frequent. Major symptoms in cases of GPA with endobronchial involvement include shortness of breath, cough, bloody sputum, and wheezing. Subglottic stenosis, frequently observed in the early stages, is a significant finding. Visualizing the airways endoscopically/bronchoscopically continues to be the primary diagnostic procedure for evaluating airway disease (1). There are very few studies investigating the significance of endobronchial involvement in GPA. It has been reported that the majority of cases of GPA with active endobronchial lesions (EBL) may have involvement of more organs and systems, primarily including the ear, nose, and throat (2). In a recent study focusing on the evaluation of EBL in GPA using fiberoptic bronchoscopy (FOB), it was found that EBL was detected in 19% of cases. In terms of frequency, mucosal inflammation, hemorrhage, ulcers, mass-like lesions, and inflammatory strictures have been reported in descending order. In this study, the authors emphasized the necessity of performing FOB in cases with respiratory symptoms to rule out alveolar hemorrhage and potential infections (3).

Wong MD et al (4) emphasized the importance of early diagnosis and treatment in cases of GPA with endobronchial involvement. They highlighted that the endobronchial involvement could be a sign of acute pulmonary capillaritis, which can lead to fatal respiratory failure due to widespread alveolar hemorrhage.

Figure 1A: The chest X-ray taken at the time of admission.

Figure 2: Cavitary lesions on thoracic CT

Figure 3: Bronchoscopic evaluation of the patient. Swollen, white-colored lesions located on the mucosa of the secondary carinas of bilateral upper lobes.

Figure 4: In the bronchoscopic biopsy sample, there is a mixed type of inflammatory cell infiltration with a predominant neutrophil (suppurative) concentrated around the necrotic focus and a few giant cells. B- Histiocytes scattered on the background and 3 giant cells.

Shah R et al (5) reported that life-threatening endobronchial involvement can occur in diseases like GPA. Therefore, they emphasized that early diagnosis of endobronchial disease could be of vital importance in preventing bronchomalacia and advanced airway obstructions.

This article presents a case of GPA in a 47-year-old male patient who presented with complaints of bloody nasal discharge, weakness, weight loss, cough, and wheezing. In addition nasal septum ulceration, vasculitic lesions on the skin (papular lesions), cavitary lung lesion (Figure 1-2), and kidney involvement (glomerular fibrosclerotic crescent) were present. The patient was diagnosed with GPA by lung and kidney biopsies, along with PR3-ANCA (97.7 RU/ml) positivity. Treatment was initiated with Methylprednisolone and Cyclophosphamide. The case was presented to draw attention to GPA endobronchial involvement, as active endobronchial lesions were detected via FOB (Figure 3-5).

Conflict of interest

I and my spouse/partner have had no relevant financial interests or  personal affiliation.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest: None declared

Declaration of Generative Artificial intelligence and Artificial intelligence-assisted technologies in the writing process: Artificial intelligence was not used during the writing of this article.

References

  1. Polychronopoulos VS, Prakash UB, Golbin JM, et al. Airway involvement in Wegener's granulomatosis. Rheum Dis Clin North Am. 2007;33(4):755-vi.
  2. Quinn KA, Gelbard A, Sibley C, et al. Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis. Rheumatology (Oxford). 2019:1;58(12):2203-2211.
  3. Villeneuve T, Prévot G, Pugnet G, et al. Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis. ERJ Open Res. 2023:11;9(5):00141-2023.
  4. Wong MD, Gauld LM. Endobronchial vasculitis in childhood granulomatosis with polyangiitis. Respirol Case Rep. 2021;9(4):e00729.
  5. Shah R, Lim L, Nikpour M. Endobronchial obstruction in connective tissue diseases: an uncommon but life threatening complication: two case reports. J Med Case Rep. 2023;17(1):329.
TOP